Description
Mimicipar 60 mg tablet has an active ingredient called Cinacalcet. It is a drug belonging to the group of calcimimetics that are used to decrease the levels of parathyroid hormone, calcium and phosphorus in the body. This medicine is mostly recommended to adults with chronic kidney disease (CKD) on dialysis and secondary hyperparathyroidism, as well as those with parathyroid carcinoma.Key Information & IndicationsPrimary Indications: Treatment of secondary hyperparathyroidism, hypercalcemia associated with parathyroid carcinoma, and primary hyperparathyroidism.Action: The medicine enhances the sensitivity of calcium-sensing receptors in the parathyroid glands and decreases the production of PTH and calcium.Dosage: Take the tablets whole. Should be taken together with food or after eating. The dosage of the medicine will depend on your particular condition, test results and advice of your healthcare professional.Special Instructions: Do not break or chew the tablet. Since this medicine lowers the level of calcium in the blood, its regular monitoring is required.

Reviews
There are no reviews yet.